Tag: Gonorrhea
FDA Approves First At-Home Test to Diagnose Three STIs in Women
The Visby Medical Women's Sexual Health Test received marketing authorization to diagnose chlamydia, gonorrhea, and trichomoniasis in women
Guideline Adherence Suboptimal for Chlamydia, Gonorrhea Treatment
14.0 percent of chlamydia cases and 38.7 percent of gonorrhea cases receive treatment with recommended antibiotic
America’s Epidemic of STDs May Finally Be Slowing
2022 Saw More Than 2.5 Million Cases of Chlamydia, Gonorrhea, Syphilis
Concerns center around syphilis and congenital syphilis, which increased 17.0 and 30.6 percent in one year
First OTC Test for Chlamydia, Gonorrhea Approved by the FDA
Approval establishes a new device classification, meaning other similar home tests could potentially have an easier approval process in the future
New Antibiotic Tackles Drug-Resistant Gonorrhea in Trial
Zoliflodacin was seen to cure uncomplicated gonorrhea infection as effectively as the current go-to treatment
2021 Syphilis Rates Increased by Nearly One-Third in the United States
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in 2021
Two Cases of New Drug-Resistant Gonorrhea Strain Reported in Massachusetts
The two cases do not appear to have a direct connection to each other
USPSTF Urges Screening Young Women for Chlamydia, Gonorrhea
All sexually active women aged 24 years and younger should be screened as well as women older than 25 at high risk
Single-Drug Regimen Now Advised for Uncomplicated Gonorrhea
Single 500-mg intramuscular dose of ceftriaxone recommended for uncomplicated urogenital, anorectal, pharyngeal gonorrhea
